Dominari Holdings Provides Update on Share Repurchase Program

Rhea-AI Summary

Dominari Holdings Inc. (Nasdaq: DOMH) provided an update on its $2 million share repurchase program authorized on December 5, 2022. On February 7, 2023, the Company repurchased 5,000 shares at $4.0475 per share. The repurchase will continue subject to market conditions and regulatory limitations. Dominari, previously focused on therapeutics, is transitioning to fintech and financial services following a registered broker-dealer acquisition. The transition will occur through its subsidiary, Dominari Financial Inc., while therapeutics will continue through Aikido Labs, LLC.

Positive

• The share repurchase program indicates confidence in the company's stock value.
• Repurchasing shares may enhance shareholder value through increased earnings per share (EPS).
• Transitioning to fintech could open new revenue opportunities for Dominari.

Negative

• None.

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on December 5, 2022.

The Company reported that on February 7, 2023, the Company purchased 5,000 shares of common stock at $4.0475 per share.

Additional shares may be repurchased from time to time in open market transactions, or other means in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 10b -18 of the Exchange Act. The timing, number of shares repurchased, and prices paid for the stock under this program will depend on general business and market conditions as well as corporate and regulatory limitations, including blackout period restrictions.

About Dominari Holdings Inc.

Dominari Holdings Inc. (f/k/a Aikido Pharma Inc.) until recently was focused primarily on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. In September 2022, the Company agreed to acquire a registered broker-dealer and transition its primary business operations to fintech and financial services.  Upon the final closing of this acquisition, the Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. The Company continues to develop its therapeutics and related patent technology, as well as other ventures, through its subsidiary, Aikido Labs, LLC. 

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:      

Hayden IR
Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

Dominari Holdings Inc. (f/k/a AIkido Pharma Inc):    

Phone: 212-745-1373
Email: investorrelations@aikidopharma.com
www.aikidopharma.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dominari-holdings-provides-update-on-share-repurchase-program-301741541.html

SOURCE Dominari Holdings Inc.

FAQ

What is the purpose of Dominari Holdings Inc.'s share repurchase program?

The share repurchase program aims to enhance shareholder value by reducing the number of outstanding shares, potentially increasing earnings per share (EPS).

When did Dominari Holdings Inc. initiate its share repurchase program?

The share repurchase program was authorized on December 5, 2022.

How many shares did Dominari Holdings Inc. repurchase on February 7, 2023?

On February 7, 2023, Dominari Holdings Inc. repurchased 5,000 shares.

What was the price per share for the repurchase made on February 7, 2023?

The shares were repurchased at a price of $4.0475 per share.

How will Dominari Holdings Inc. fund its share repurchase program?

Dominari Holdings Inc. will fund its share repurchase program through general business operations and market transactions, guided by regulatory limitations.